{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-201697","form_type":"8-K","ticker":"PSNL","cik":"0001527753","company_name":"Personalis, Inc.","filed_at":"2024-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.391985+00:00","generated_at":"2026-05-31T08:50:01.015413+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tempus invests $36M in Personalis, exercises warrants and buys shares; expands commercial collaboration","bullets":["Tempus exercises warrants for 9.2M shares at avg $2.00 ($18.4M) and buys 3.5M shares at $5.07 ($17.7M).","Total investment ~$36M; Tempus will own ~19.3% of Personalis outstanding common stock.","Partners accelerate commercialization of ultra-sensitive MRD testing for breast, lung, and immunotherapy monitoring.","Personalis to increase patient sample capacity; Tempus expands commercialization efforts over first two years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-201697","json":"https://secwatch.observer/filing/0001193125-24-201697.json","markdown":"https://secwatch.observer/filing/0001193125-24-201697.md","text":"https://secwatch.observer/filing/0001193125-24-201697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527753/000119312524201697/0001193125-24-201697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527753/000119312524201697/d836724d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:50:01.015413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}